Skip to main content
Erschienen in: Current Cardiology Reports 9/2016

01.09.2016 | Invasive Electrophysiology and Pacing (EK Heist, Section Editor)

Incomplete Closure of the Left Atrial Appendage: Implication and Management

verfasst von: Arash Aryana, André d’Avila

Erschienen in: Current Cardiology Reports | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Incomplete left atrial appendage closure (LAAC) occurs in ∼30–40 % of cases following both surgical and percutaneous closure methods. Incomplete surgical LAAC may further be classified as incompletely surgically ligated LAA (ISLL) or LAA stump. ISLL is associated with a significantly increased risk of thrombus formation/thromboembolism. Moreover, this risk is highest in the absence of oral anticoagulation (OAC) and inversely correlates with the size of the ISLL neck. Not only routine screening for ISLL seems critical, but also long-term OAC should strongly be considered in this high-risk cohort. Alternatively, complete endocardial occlusion using a surrogate method may represent a reasonable option, particularly in those intolerant to long-term OAC therapy. Although thrombus formation/thromboembolic events have also been described in patients with incomplete LAAC following percutaneous occlusion, an association between the two remains less clear. However, given the rise and growing interest in percutaneous LAAC methods, additional research in this area is clearly warranted.
Literatur
1.
Zurück zum Zitat Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983–8.PubMedCrossRef Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke. 1991;22:983–8.PubMedCrossRef
2.
Zurück zum Zitat Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.PubMedCrossRef Hart RG, Pearce LA, Aguilar MI. Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med. 2007;146:857–67.PubMedCrossRef
3.
Zurück zum Zitat Glader EL, Sjolander M, Eriksson M, et al. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41:397–401.PubMedCrossRef Glader EL, Sjolander M, Eriksson M, et al. Persistent use of secondary preventive drugs declines rapidly during the first 2 years after stroke. Stroke. 2010;41:397–401.PubMedCrossRef
4.
Zurück zum Zitat Connolly SJ, Ezekowitz MD, Yusuf S, RE-LY Steering Committee and Investigators, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.PubMedCrossRef Connolly SJ, Ezekowitz MD, Yusuf S, RE-LY Steering Committee and Investigators, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med. 2009;361:1139–51.PubMedCrossRef
5.
Zurück zum Zitat Patel MR, Mahaffey KW, Garg J, ROCKET AF Investigators, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.PubMedCrossRef Patel MR, Mahaffey KW, Garg J, ROCKET AF Investigators, et al. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. N Engl J Med. 2011;365:883–91.PubMedCrossRef
6.
Zurück zum Zitat Granger CB, Alexander JH, McMurray JJ, ARISTOTLE Committees and Investigators, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.PubMedCrossRef Granger CB, Alexander JH, McMurray JJ, ARISTOTLE Committees and Investigators, et al. Apixaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2011;365:981–92.PubMedCrossRef
7.
Zurück zum Zitat Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.PubMedCrossRef Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61:755–9.PubMedCrossRef
8.
Zurück zum Zitat Cruz-Gonzalez I, Yan BP, Lam YY. Left atrial appendage exclusion: state-of-the-art. Catheter Cardiovasc Interv. 2010;75:806–13.PubMedCrossRef Cruz-Gonzalez I, Yan BP, Lam YY. Left atrial appendage exclusion: state-of-the-art. Catheter Cardiovasc Interv. 2010;75:806–13.PubMedCrossRef
9.
Zurück zum Zitat Johnson WD, Ganjoo AK, Stone CD, et al. The left atrial appendage: our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg. 2000;17:718–22.PubMedCrossRef Johnson WD, Ganjoo AK, Stone CD, et al. The left atrial appendage: our most lethal human attachment! Surgical implications. Eur J Cardiothorac Surg. 2000;17:718–22.PubMedCrossRef
10.
Zurück zum Zitat Mahajan R, Brooks AG, Sullivan T, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart. 2012;98:1120–6.PubMedCrossRef Mahajan R, Brooks AG, Sullivan T, et al. Importance of the underlying substrate in determining thrombus location in atrial fibrillation: implications for left atrial appendage closure. Heart. 2012;98:1120–6.PubMedCrossRef
11.
Zurück zum Zitat Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109–18.PubMedCrossRef Di Biase L, Burkhardt JD, Mohanty P, Sanchez J, Mohanty S, Horton R, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122:109–18.PubMedCrossRef
12.
Zurück zum Zitat Cabrera JA, Ho SY, Climent V, Sánchez-Quintana D. The architecture of the left lateral atrial wall: a particular anatomic region with implications for ablation of atrial fibrillation. Eur Heart J. 2008;29:356–62.PubMedCrossRef Cabrera JA, Ho SY, Climent V, Sánchez-Quintana D. The architecture of the left lateral atrial wall: a particular anatomic region with implications for ablation of atrial fibrillation. Eur Heart J. 2008;29:356–62.PubMedCrossRef
13.
Zurück zum Zitat Afzal MR, Kanmanthareddy A, Earnest M, Reddy M, Atkins D, Bommana S, et al. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Heart Rhythm. 2015;12:52–9.PubMedCrossRef Afzal MR, Kanmanthareddy A, Earnest M, Reddy M, Atkins D, Bommana S, et al. Impact of left atrial appendage exclusion using an epicardial ligation system (LARIAT) on atrial fibrillation burden in patients with cardiac implantable electronic devices. Heart Rhythm. 2015;12:52–9.PubMedCrossRef
14.
Zurück zum Zitat Bonow RO, Carabello BA, Chatterjee K, 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force: 2008, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523–661.PubMedCrossRef Bonow RO, Carabello BA, Chatterjee K, 2006 Writing Committee Members; American College of Cardiology/American Heart Association Task Force: 2008, et al. Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation. 2008;118:e523–661.PubMedCrossRef
15.
Zurück zum Zitat Katz ES, Tsiamtsiouris T, Applebaum RM, et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study. J Am Coll Cardiol. 2000;36:468–71.PubMedCrossRef Katz ES, Tsiamtsiouris T, Applebaum RM, et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiographic study. J Am Coll Cardiol. 2000;36:468–71.PubMedCrossRef
16.
Zurück zum Zitat García-Fernández MA, Pérez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol. 2003;42:1253–8.PubMedCrossRef García-Fernández MA, Pérez-David E, Quiles J, et al. Role of left atrial appendage obliteration in stroke reduction in patients with mitral valve prosthesis: a transesophageal echocardiographic study. J Am Coll Cardiol. 2003;42:1253–8.PubMedCrossRef
17.
Zurück zum Zitat Cullen MW, Stulak JM, Li Z, et al. Left atrial appendage patency at cardioversion after surgical left atrial appendage intervention. Ann Thorac Surg. 2016;101:675–81.PubMedCrossRef Cullen MW, Stulak JM, Li Z, et al. Left atrial appendage patency at cardioversion after surgical left atrial appendage intervention. Ann Thorac Surg. 2016;101:675–81.PubMedCrossRef
18.
Zurück zum Zitat Kanderian AS, Gillinov AM, Pettersson GB, et al. Success of surgical left atrial appendage closure—assessment by transoesophageal echocardiography. J Am Coll Cardiol. 2008;52:924–9.PubMedCrossRef Kanderian AS, Gillinov AM, Pettersson GB, et al. Success of surgical left atrial appendage closure—assessment by transoesophageal echocardiography. J Am Coll Cardiol. 2008;52:924–9.PubMedCrossRef
19.
Zurück zum Zitat Healey JS, Crystal E, Lamy A, et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150:288–93.PubMedCrossRef Healey JS, Crystal E, Lamy A, et al. Left Atrial Appendage Occlusion Study (LAAOS): results of a randomized controlled pilot study of left atrial appendage occlusion during coronary bypass surgery in patients at risk for stroke. Am Heart J. 2005;150:288–93.PubMedCrossRef
20.
Zurück zum Zitat Bando K, Kobayashi J, Hirata M, et al. Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience. J Thorac Cardiovasc Surg. 2003;126:358–64.PubMedCrossRef Bando K, Kobayashi J, Hirata M, et al. Early and late stroke after mitral valve replacement with a mechanical prosthesis: risk factor analysis of a 24-year experience. J Thorac Cardiovasc Surg. 2003;126:358–64.PubMedCrossRef
21.•
Zurück zum Zitat Aryana A, Singh SK, Singh SM, et al. Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization. Heart Rhythm. 2015;12:1431–7. The authors illustrate that in patients with atrial fibrillation, incompletely surgically-ligated left atrial appendage is a predictor of stroke/systemic embolization, independent of conventional risk stratification schemes. Consequently, oral anticoagulation should be strongly considered in this high-risk cohort.PubMedCrossRef Aryana A, Singh SK, Singh SM, et al. Association between incomplete surgical ligation of left atrial appendage and stroke and systemic embolization. Heart Rhythm. 2015;12:1431–7. The authors illustrate that in patients with atrial fibrillation, incompletely surgically-ligated left atrial appendage is a predictor of stroke/systemic embolization, independent of conventional risk stratification schemes. Consequently, oral anticoagulation should be strongly considered in this high-risk cohort.PubMedCrossRef
22.
Zurück zum Zitat Dawson AG, Asopa S, Dunning J. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? Interact Cardiovasc Thorac Surg. 2010;10:306–11.PubMedCrossRef Dawson AG, Asopa S, Dunning J. Should patients undergoing cardiac surgery with atrial fibrillation have left atrial appendage exclusion? Interact Cardiovasc Thorac Surg. 2010;10:306–11.PubMedCrossRef
23.
Zurück zum Zitat Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531–8.PubMedCrossRef Di Biase L, Santangeli P, Anselmino M, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60:531–8.PubMedCrossRef
25.•
Zurück zum Zitat Khurram IM, Dewire J, Mager M, et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm. 2013;10:1843–9. The authors show that in a large cohort of patients with drug-refractory atrial fibrillation undergoing catheter ablation therapy, the extent of left atrial appendage trabeculation and a smaller left atrial appendage orifice diameter were associated with increased prevalence of stroke or transient ischemic attack.PubMedCrossRef Khurram IM, Dewire J, Mager M, et al. Relationship between left atrial appendage morphology and stroke in patients with atrial fibrillation. Heart Rhythm. 2013;10:1843–9. The authors show that in a large cohort of patients with drug-refractory atrial fibrillation undergoing catheter ablation therapy, the extent of left atrial appendage trabeculation and a smaller left atrial appendage orifice diameter were associated with increased prevalence of stroke or transient ischemic attack.PubMedCrossRef
26.
Zurück zum Zitat Schneider B, Stollberger C, Sievers HH. Surgical closure of the left atrial appendage—a beneficial procedure? Cardiology. 2005;104:127–32.PubMedCrossRef Schneider B, Stollberger C, Sievers HH. Surgical closure of the left atrial appendage—a beneficial procedure? Cardiology. 2005;104:127–32.PubMedCrossRef
27.
Zurück zum Zitat Aryana A, Saad EB, d’Avila A. Left atrial appendage occlusion and ligation devices: what is available, how to implement them, and how to manage and avoid complications. Curr Treat Options Cardiovasc Med. 2012;14:503–19.PubMedCrossRef Aryana A, Saad EB, d’Avila A. Left atrial appendage occlusion and ligation devices: what is available, how to implement them, and how to manage and avoid complications. Curr Treat Options Cardiovasc Med. 2012;14:503–19.PubMedCrossRef
28.
Zurück zum Zitat Bordignon S, Fürnkranz A, Perrotta L, et al. Filling the gap: interventional occlusion of incompletely ligated left atrial appendages. Europace. 2015;17:64–8.PubMedCrossRef Bordignon S, Fürnkranz A, Perrotta L, et al. Filling the gap: interventional occlusion of incompletely ligated left atrial appendages. Europace. 2015;17:64–8.PubMedCrossRef
29.•
Zurück zum Zitat Aryana A, Cavaco D, Arthur A, et al. Percutaneous endocardial occlusion of incompletely surgically ligated left atrial appendage. J Cardiovasc Electrophysiol. 2013;24:968–74. The authors describe a novel approach for percutaneous endocardial occlusion of incompletely surgically-ligated left atrial appendage using an Amplatzer Septal Occluder device in a small cohort of patients with non-valvular atrial fibrillation.PubMedCrossRef Aryana A, Cavaco D, Arthur A, et al. Percutaneous endocardial occlusion of incompletely surgically ligated left atrial appendage. J Cardiovasc Electrophysiol. 2013;24:968–74. The authors describe a novel approach for percutaneous endocardial occlusion of incompletely surgically-ligated left atrial appendage using an Amplatzer Septal Occluder device in a small cohort of patients with non-valvular atrial fibrillation.PubMedCrossRef
30.
Zurück zum Zitat Matsumoto T, Nakamura M, Yeow WL, et al. Transcatheter left atrial appendage closure after incomplete surgical ligation. JACC Cardiovasc Interv. 2013;6:e11–2.PubMedCrossRef Matsumoto T, Nakamura M, Yeow WL, et al. Transcatheter left atrial appendage closure after incomplete surgical ligation. JACC Cardiovasc Interv. 2013;6:e11–2.PubMedCrossRef
31.
Zurück zum Zitat Levisay JP, Sangodkar S, Salinger MH, et al. Percutaneous vascular plug for incomplete surgical left atrial appendage closure. J Invasive Cardiol. 2014;26:180–2.PubMed Levisay JP, Sangodkar S, Salinger MH, et al. Percutaneous vascular plug for incomplete surgical left atrial appendage closure. J Invasive Cardiol. 2014;26:180–2.PubMed
32.
Zurück zum Zitat Kreidieh B, Rojas F, Schurmann P, et al. Left atrial appendage remodeling after lariat left atrial appendage ligation. Circ Arrhythm Electrophysiol. 2015;8:1351–8.PubMed Kreidieh B, Rojas F, Schurmann P, et al. Left atrial appendage remodeling after lariat left atrial appendage ligation. Circ Arrhythm Electrophysiol. 2015;8:1351–8.PubMed
33.
Zurück zum Zitat Bai R, Horton RP, Di Biase L, et al. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience. J Cardiovasc Electrophysiol. 2012;23:455–61.PubMedCrossRef Bai R, Horton RP, Di Biase L, et al. Intraprocedural and long-term incomplete occlusion of the left atrial appendage following placement of the WATCHMAN device: a single center experience. J Cardiovasc Electrophysiol. 2012;23:455–61.PubMedCrossRef
34.
Zurück zum Zitat Hanazawa K, Brunelli M, Geller JC. Thromboembolic stroke after cardioversion with incomplete left atrial appendage closure. Clin Res Cardiol. 2014;103:835–7.PubMedCrossRef Hanazawa K, Brunelli M, Geller JC. Thromboembolic stroke after cardioversion with incomplete left atrial appendage closure. Clin Res Cardiol. 2014;103:835–7.PubMedCrossRef
35.
Zurück zum Zitat Vorselaars VM, Velthuis S, Swaans MJ, et al. Percutaneous left atrial appendage closure—an alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia? Cardiovasc Diagn Ther. 2015;5:49–53.PubMedPubMedCentral Vorselaars VM, Velthuis S, Swaans MJ, et al. Percutaneous left atrial appendage closure—an alternative strategy for anticoagulation in atrial fibrillation and hereditary hemorrhagic telangiectasia? Cardiovasc Diagn Ther. 2015;5:49–53.PubMedPubMedCentral
36.
Zurück zum Zitat Lam SC, Bertog S, Sievert H. Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer Cardiac Plug (Amulet device). Catheter Cardiovasc Interv. 2015;85:321–7.PubMedCrossRef Lam SC, Bertog S, Sievert H. Incomplete left atrial appendage occlusion and thrombus formation after Watchman implantation treated with anticoagulation followed by further transcatheter closure with a second-generation Amplatzer Cardiac Plug (Amulet device). Catheter Cardiovasc Interv. 2015;85:321–7.PubMedCrossRef
37.•
Zurück zum Zitat Price MJ, Gibson DN, Yakubov SJ, et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol. 2014;64:565–72. In this multicenter experience of left atrial appendage ligation with the LARIAT device, as many as 20 % of the patients were found to exhibit a residual leak during follow-up and 5 % of the patients developed thrombi.PubMedPubMedCentralCrossRef Price MJ, Gibson DN, Yakubov SJ, et al. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium. J Am Coll Cardiol. 2014;64:565–72. In this multicenter experience of left atrial appendage ligation with the LARIAT device, as many as 20 % of the patients were found to exhibit a residual leak during follow-up and 5 % of the patients developed thrombi.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Holmes DR, Reddy VY, Turi ZG, PROTECT AF Investigators, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42.PubMedCrossRef Holmes DR, Reddy VY, Turi ZG, PROTECT AF Investigators, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–42.PubMedCrossRef
39.
Zurück zum Zitat Holmes Jr DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12.PubMedCrossRef Holmes Jr DR, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014;64:1–12.PubMedCrossRef
40.
Zurück zum Zitat Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. Euro Intervention. 2016;11:1170–9.PubMed Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. Euro Intervention. 2016;11:1170–9.PubMed
41.
Zurück zum Zitat Bartus K, Han FT, Bednarek J, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62:108–18.PubMedCrossRef Bartus K, Han FT, Bednarek J, et al. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience. J Am Coll Cardiol. 2013;62:108–18.PubMedCrossRef
42.
Zurück zum Zitat Gafoor S, Franke J, Bertog S, et al. Left atrial appendage occlusion in octogenarians: short-term and 1-year follow-up. Catheter Cardiovasc Interv. 2014;83:805–10.PubMedCrossRef Gafoor S, Franke J, Bertog S, et al. Left atrial appendage occlusion in octogenarians: short-term and 1-year follow-up. Catheter Cardiovasc Interv. 2014;83:805–10.PubMedCrossRef
43.
Zurück zum Zitat Baker MS, Paul Mounsey J, Gehi AK, et al. Left atrial thrombus after appendage ligation with LARIAT. Heart Rhythm. 2014;11:1489.PubMedCrossRef Baker MS, Paul Mounsey J, Gehi AK, et al. Left atrial thrombus after appendage ligation with LARIAT. Heart Rhythm. 2014;11:1489.PubMedCrossRef
44.
Zurück zum Zitat Briceno DF, Fernando RR, Laing ST. Left atrial appendage thrombus post LARIAT closure device. Heart Rhythm. 2014;11:1600–1.PubMedCrossRef Briceno DF, Fernando RR, Laing ST. Left atrial appendage thrombus post LARIAT closure device. Heart Rhythm. 2014;11:1600–1.PubMedCrossRef
45.
Zurück zum Zitat Giedrimas E, Lin AC, Knight BP. Left atrial thrombus after appendage closure using LARIAT. Circ Arrhythm Electrophysiol. 2013;6:e52–3.PubMedCrossRef Giedrimas E, Lin AC, Knight BP. Left atrial thrombus after appendage closure using LARIAT. Circ Arrhythm Electrophysiol. 2013;6:e52–3.PubMedCrossRef
46.
Zurück zum Zitat Truesdell AG, Patel CP, Maini BS. Late-occurring left atrial appendage thrombus after ligation using LARIAT. J Interv Card Electrophysiol. 2014;41:101.PubMedCrossRef Truesdell AG, Patel CP, Maini BS. Late-occurring left atrial appendage thrombus after ligation using LARIAT. J Interv Card Electrophysiol. 2014;41:101.PubMedCrossRef
47.
Zurück zum Zitat Viles-Gonzalez JF, Reddy VY, Petru J, et al. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke. J Interv Card Electrophysiol. 2012;33:69–75.PubMedCrossRef Viles-Gonzalez JF, Reddy VY, Petru J, et al. Incomplete occlusion of the left atrial appendage with the percutaneous left atrial appendage transcatheter occlusion device is not associated with increased risk of stroke. J Interv Card Electrophysiol. 2012;33:69–75.PubMedCrossRef
48.
Zurück zum Zitat Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol. 2012;59:923–9.PubMedCrossRef Viles-Gonzalez JF, Kar S, Douglas P, et al. The clinical impact of incomplete left atrial appendage closure with the Watchman Device in patients with atrial fibrillation: a PROTECT AF (Percutaneous Closure of the Left Atrial Appendage Versus Warfarin Therapy for Prevention of Stroke in Patients With Atrial Fibrillation) substudy. J Am Coll Cardiol. 2012;59:923–9.PubMedCrossRef
49.
Zurück zum Zitat Budera P, Straka Z, Osmančík P, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33:2644–52.PubMedPubMedCentralCrossRef Budera P, Straka Z, Osmančík P, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33:2644–52.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Whitlock R, Healey J, Vincent J, et al. Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Ann Cardiothorac Surg. 2014;3:45–54.PubMedPubMedCentral Whitlock R, Healey J, Vincent J, et al. Rationale and design of the Left Atrial Appendage Occlusion Study (LAAOS) III. Ann Cardiothorac Surg. 2014;3:45–54.PubMedPubMedCentral
51.
Zurück zum Zitat Wunderlich N, Wilson N, Sievert H. A novel approach to treat residual peridevice leakage after left-atrial appendage closure. Catheter Cardiovasc Interv. 2013;82:313–9.PubMedCrossRef Wunderlich N, Wilson N, Sievert H. A novel approach to treat residual peridevice leakage after left-atrial appendage closure. Catheter Cardiovasc Interv. 2013;82:313–9.PubMedCrossRef
52.•
Zurück zum Zitat Pillai AM, Kanmanthareddy A, Earnest M, et al. Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application. Heart Rhythm. 2014;11:1877–83. In this study, the authors show that left atrial appendage leaks from incomplete ligation the LARIAT procedure is not uncommon and can be successfully closed using an Amplatzer Septal Occluder device and in some cases using a repeat Lariat procedure.PubMedCrossRef Pillai AM, Kanmanthareddy A, Earnest M, et al. Initial experience with post Lariat left atrial appendage leak closure with Amplatzer septal occluder device and repeat Lariat application. Heart Rhythm. 2014;11:1877–83. In this study, the authors show that left atrial appendage leaks from incomplete ligation the LARIAT procedure is not uncommon and can be successfully closed using an Amplatzer Septal Occluder device and in some cases using a repeat Lariat procedure.PubMedCrossRef
53.
Zurück zum Zitat Labovitz AJ, for the STEPS Investigators. Transesophageal echocardiography in patients with unexplained cerebral ischemia: multicenter findings. Circulation. 1994;90:1–21a. Labovitz AJ, for the STEPS Investigators. Transesophageal echocardiography in patients with unexplained cerebral ischemia: multicenter findings. Circulation. 1994;90:1–21a.
54.
Zurück zum Zitat Vigna C, Russo A, De Rito V, et al. Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy. Am J Cardiol. 1992;70:1500–1.PubMedCrossRef Vigna C, Russo A, De Rito V, et al. Frequency of left atrial thrombi by transesophageal echocardiography in idiopathic and in ischemic dilated cardiomyopathy. Am J Cardiol. 1992;70:1500–1.PubMedCrossRef
55.
Zurück zum Zitat Mügge A, Daniel WG, Hausmann D, et al. Diagnosis of left atrial appendage thrombi by transesophageal echocardiography: clinical implications and follow-up. Am J Cardiac Imag. 1990;4:173–9. Mügge A, Daniel WG, Hausmann D, et al. Diagnosis of left atrial appendage thrombi by transesophageal echocardiography: clinical implications and follow-up. Am J Cardiac Imag. 1990;4:173–9.
56.
Zurück zum Zitat Aryana A, Bailey S, Gearoid O’Neill P, d’Avila A. Endocardial occlusion of incompletely surgically ligated left atrial appendage using an Amplatzer septal occluder device. Heart Rhythm. 2014;11:735–6.PubMedCrossRef Aryana A, Bailey S, Gearoid O’Neill P, d’Avila A. Endocardial occlusion of incompletely surgically ligated left atrial appendage using an Amplatzer septal occluder device. Heart Rhythm. 2014;11:735–6.PubMedCrossRef
Metadaten
Titel
Incomplete Closure of the Left Atrial Appendage: Implication and Management
verfasst von
Arash Aryana
André d’Avila
Publikationsdatum
01.09.2016
Verlag
Springer US
Erschienen in
Current Cardiology Reports / Ausgabe 9/2016
Print ISSN: 1523-3782
Elektronische ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-016-0765-2

Weitere Artikel der Ausgabe 9/2016

Current Cardiology Reports 9/2016 Zur Ausgabe

Echocardiography (JM Gardin, Section Editor)

Echocardiography in Pregnancy: Part 2

Stroke (JF Meschia, Section Editor)

Management of Symptomatic Intracranial Stenosis

Cardiac PET, CT, and MRI (SE Petersen and F Pugliese, Section Editors)

Intravascular MRI for Plaque Characterization: Are We Close to Reality?

Heart Failure (MR Mehra and E Joyce, Section Editors)

Is Heart Rate a Norepiphenomenon in Heart Failure?

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.